News
06-16-2010, 04:50 AM
AVEO Pharmaceuticals, Inc., a biopharmaceutical company focused on discovering, developing and commercializing cancer therapeutics, today announced the issuance of U.S. Patent Nos. 7,615,353, which issued in November 2009, and 7,736,861, which issued yesterday.
More... (http://www.news-medical.net/news/20100616/AVEO-granted-patents-for-tests-to-identify-cancer-patients-likely-to-respond-to-tivozanib.aspx)
More... (http://www.news-medical.net/news/20100616/AVEO-granted-patents-for-tests-to-identify-cancer-patients-likely-to-respond-to-tivozanib.aspx)